Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Heart Rhythm. 2023 Dec;20(12):1752-1758. doi: 10.1016/j.hrthm.2023.08.034. Epub 2023 Aug 28.
Guidelines addressing magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIEDs) provide algorithms for imaging pediatric and congenital heart disease (CHD) patients. Guideline acceptance varies by institution. Guidelines also do not support routine MRI scans in patients with epicardial or abandoned leads, common in pediatric and CHD patients.
The purpose of this study was to determine the incidence of MRI-related complications in pediatric and CHD patients with CIEDs, including epicardial and/or abandoned leads.
A multicenter retrospective review included patients with CIEDs who underwent any MRI between 2007 and 2022 at congenital cardiac centers. The primary outcome was any patient adverse event or clinically significant CIED change after MRI, defined as pacing lead capture threshold increase >0.5 V with output change, P- or R- wave amplitude decrease >50% with sensitivity change, or impedance change >50%.
Across 14 institutions, 314 patients (median age 18.8 [1.3; 31.4] years) underwent 389 MRIs. There were 288 pacemakers (74%) and 87 implantable cardioverter-defibrillators (22%); 52% contained epicardial leads, and 14 (4%) were abandoned leads only. Symptoms or CIED changes occurred in 4.9% of MRI scans (6.1% of patients). On 9 occasions (2%), warmth or pain occurred. Pacing capture threshold or lead impedance changes occurred in 1.4% and 2.0% of CIEDs post-MRI and at follow-up.
Our data provide evidence that MRIs can be performed in pediatric and CHD patients with CIEDs, including non-MRI-conditional CIEDs and epicardial and/or abandoned leads, with rare minor symptoms or CIED changes but no other complications.
针对患有心脏植入式电子设备 (CIED) 的患者的磁共振成像 (MRI) 的指南提供了用于成像儿科和先天性心脏病 (CHD) 患者的算法。指南的接受程度因机构而异。指南也不支持在有心外膜或废弃导线的患者中进行常规 MRI 扫描,而这些患者在儿科和 CHD 患者中很常见。
本研究旨在确定在患有 CIED 的儿科和 CHD 患者中进行 MRI 的相关并发症发生率,包括心外膜和/或废弃导线。
一项多中心回顾性研究纳入了 2007 年至 2022 年期间在先天性心脏病中心接受任何 MRI 的 CIED 患者。主要结果是 MRI 后任何患者不良事件或有临床意义的 CIED 变化,定义为起搏导线捕获阈值增加>0.5 V,输出变化,P 或 R 波幅度降低>50%,灵敏度变化,或阻抗变化>50%。
在 14 家机构中,314 名患者(中位年龄 18.8 [1.3;31.4] 岁)接受了 389 次 MRI。其中 288 个为起搏器(74%),87 个为植入式心律转复除颤器(22%);52% 含有心外膜导线,14 个(4%)仅为废弃导线。MRI 扫描中 4.9%(6.1%的患者)出现症状或 CIED 变化。有 9 次(2%)出现发热或疼痛。MRI 后和随访时,1.4%和 2.0%的 CIED 出现起搏捕获阈值或导线阻抗变化。
我们的数据提供了证据,表明可以在患有 CIED 的儿科和 CHD 患者中进行 MRI,包括非 MRI 条件下的 CIED 以及心外膜和/或废弃导线,很少出现轻微症状或 CIED 变化,但没有其他并发症。